Articles

It is not “just hair.” Often referred to as a woman’s “crowning glory,” much of a woman’s female identity is defined by her hair—from her femininity, to age, to confidence, to style, women communicate a great deal about themselves by how they wear and style their hair. Without hair, women feel stripped of their identity, and in the context of cancer, women often feel as if they are systematically being stripped of themselves.

Read More ›

Patient navigation decreased treatment interruptions among Am - erican Indian patients receiving radiation treatment (RT) with curative intent in a recent study conducted at the Rapid City Regional Hospital Cancer Care Institute in South Dakota. The study also found a high rate of clinical trial participation among its patients. Similar patients who underwent treatment between 1991 and 2004 and did not receive navigation services acted as controls.

Read More ›

Each year, adult cancer survivors spend, on average, $4000 to $5000 more on total medical expenditures than people who have never had cancer, according to a study of survivors younger than 65 years. “These ongoing expenditures signal what oncology nurses already know…when people finish their treatment for cancer, that is not necessarily the end of it. They require ongoing support. There’s a need for heightened surveillance that extends for the rest of their lives. Read More ›


CHICAGO—Decitabine extends overall survival and improves response rates compared with standard therapies in the treatment of older patients with newly diagnosed acute myelogenous leukemia (AML), said Xavier G. Thomas, MD, PhD.

The treatment options for older patients with AML are limited. Intensive chemotherapy is generally poorly tolerated in this group, the initial mortality rate is high (exceeding 30% at 8 weeks), the response rate to chemotherapy is poor, and relapse rates are high.

Read More ›

Genetic counseling as a profession began in 1969 with the establishment of the first Master’slevel graduate program in genetic counseling. As a process, however, genetic counseling has evolved over a longer period of time. Read More ›

CHICAGO—Exemestane appears to be a good alternative to tamoxifen for prevention of breast cancer in postmenopausal women, according to results of the randomized, placebo-controlled MAP.3 trial. Read More ›

Susan Beausang, President of 4Women.com and designer of the patented beaubeau head scarf, comes from 3 generations of breast cancer survivors. Hav - ing watched her grandmother, aunt, mother, and 2 of 4 sisters battle breast cancer, she and her siblings underwent genetic testing. Read More ›

CHICAGO—Oncology nurses know that nutrition interventions can help their patients, both during and after active treatment. But the evidence is scant, and personalizing it for each patient can be a challenge. To help, nutrition experts provided useful tips for nurses, along with a discussion of the evidence.

Read More ›

The hot, hazy days of summer are the perfect time for some of nature’s best produce. The tomato easily could be the unspoken mascot of the summer season. From July through September, make sure you take advantage of this delicious, nutrient-dense summer favorite. Read More ›

Patients with HER2+ breast cancer who develop resistance to trastuzumab may soon have an alternative therapy, according to recent findings published in Clinical Cancer Research. This therapy involves HER2-Affitoxin, a protein that combines HER2-specific affibody molecules and a modified bacterial toxin, PE38, according to study investigator Jacek Capala, PhD, DSc, of the National Cancer Institute. Read More ›


Page 329 of 376


Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: